Philadelphia Trust Company’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$321K Hold
1,455
0.02% 208
2026
Q1
$430K Sell
1,455
-200
-12% -$59.4K 0.03% 171
2025
Q4
$452K Hold
1,655
0.03% 167
2025
Q3
$447K Sell
1,655
-45
-3% -$12.2K 0.03% 165
2025
Q2
$469K Buy
1,700
+100
+6% +$27.2K 0.04% 156
2025
Q1
$424K Buy
1,600
+145
+10% +$35.8K 0.04% 166
2024
Q4
$338K Sell
1,455
-14
-1% -$3.22K 0.02% 191
2024
Q3
$324K Buy
1,469
+14
+1% +$2.9K 0.02% 196
2024
Q2
$286K Hold
1,455
0.02% 186
2024
Q1
$313K Hold
1,455
0.03% 184
2023
Q4
$306K Buy
+1,455
New +$310K 0.03% 181
2014
Q3
Sell
-5,000
Closed -$355K 160
2014
Q2
$355K Sell
5,000
-250
-5% -$17.6K 0.02% 136
2014
Q1
$389K Hold
5,250
0.02% 140
2013
Q4
$412K Sell
5,250
-60
-1% -$4.7K 0.03% 152
2013
Q3
$392K Hold
5,310
0.03% 139
2013
Q2
$403K Buy
+5,310
New +$348K 0.03% 131

Other funds holding CME

Philadelphia Trust Company's CME Position: Q2 2026 in Review

Philadelphia Trust Company held its CME Group (CME) position steady in Q2 2026 at 1,455 shares worth $321K. The position accounts for 0.02% of the portfolio, ranked #208.

Philadelphia Trust Company first reported a position in CME in Q2 2013 and has held it in 16 quarters since. The position peaked at $469K in Q2 2025. 1,704 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Philadelphia Trust Company held 1,455 shares of CME Group worth $321K as of Q2 2026.
  • Philadelphia Trust Company left its CME Group share count unchanged in Q2 2026.
  • CME Group made up 0.02% of Philadelphia Trust Company's portfolio in Q2 2026, its #208 holding.
  • Philadelphia Trust Company first reported a position in CME Group in Q2 2013 and has held it in 16 quarters since.
  • Philadelphia Trust Company's CME Group position peaked at $469K in Q2 2025.
  • 1,704 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Philadelphia Trust Company's 13F filing for Q2 2026, filed 10 Aug 2026.